New drug shows promise for rare kidney conditions
NCT ID NCT05083364
First seen Dec 16, 2025 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This study tested an experimental drug called ARO-C3 in 62 healthy adults and patients with kidney diseases caused by an overactive immune system (C3 glomerulopathy and IgA nephropathy). The goal was to see if the drug is safe and how the body processes it. Participants received one or more doses, and the results will help decide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Auckland, 1010, New Zealand
-
Research Site 1
Camperdown, New South Wales, 2050, Australia
-
Research Site 1
Gamcheon, Busan, 49267, South Korea
-
Research Site 2
Clayton, Victoria, 3168, Australia
-
Research Site 2
Tbilisi, 0112, Georgia
-
Research Site 2
Cologne, 50937, Germany
-
Research Site 2
Haeundae, Busan, 48108, South Korea
-
Research Site 2
Bangkok, 10400, Thailand
-
Research Site 3
Concord, New South Wales, 2139, Australia
-
Research Site 3
Daegu, 42601, South Korea
-
Research Site 3
Chiang Mai, 50200, Thailand
-
Research Site 4
Erlangen, 91054, Germany
-
Research Site 4
Goyang-si, Gyeonggi-do, 10444, South Korea
-
Research Site 4
Oxford, OX3 7LE, United Kingdom
-
Research Site 6
Soeul, 03722, South Korea
-
Research Site 8
Soeul, 05030, South Korea
Conditions
Explore the condition pages connected to this study.